Travere Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Travere Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2013 to Q3 2024.
  • Travere Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 77.8M shares, a 1.93% increase year-over-year.
  • Travere Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 74.3M shares, a 16.5% increase from 2022.
  • Travere Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 63.8M shares, a 6.56% increase from 2021.
  • Travere Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 59.8M shares, a 25.9% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 77.8M +1.47M +1.93% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 77.5M +1.5M +1.97% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 77.1M +8.96M +13.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 74.3M +10.5M +16.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 76.3M +12.3M +19.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 76M +12.4M +19.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 68.2M +5.04M +7.99% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 63.8M +3.93M +6.56% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 64M +3.23M +5.31% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 63.6M +3.07M +5.06% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 63.1M +6.86M +12.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 59.8M +12.3M +25.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 60.8M +9.87M +19.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-27
Q2 2021 60.6M +15.8M +35.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 56.3M +12.7M +29.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 47.5M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 50.9M Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 44.8M Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 43.6M +2.18M +5.27% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 41.4M +1.75M +4.42% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q1 2018 39.7M +498K +1.27% Jan 1, 2018 Mar 31, 2018 10-Q/A 2018-07-06
Q4 2017 38.8M +482K +1.26% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-26
Q3 2017 38.7M +1.67M +4.53% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-07
Q2 2017 39M +2.36M +6.43% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-09
Q1 2017 39.2M +1.21M +3.19% Jan 1, 2017 Mar 31, 2017 10-Q/A 2018-07-06
Q4 2016 38.3M +707K +1.88% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 37M -5.77M -13.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 36.7M +1.73M +4.94% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 37.9M +7.57M +24.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 37.6M +12.5M +50% Oct 1, 2015 Dec 31, 2015 10-K/A 2018-07-06
Q3 2015 42.8M +14.5M +51.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 35M +7.63M +27.9% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 30.4M +7.05M +30.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 25.1M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 28.2M +12.8M +83.6% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 27.3M +15.1M +123% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 23.3M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q3 2013 15.4M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 12.3M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.